Companies: 10,795·Total market cap: $144.5T
Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited

SBMFFOTCHealthcare● Active
$0.63
+$0.00(+0.00%)
Market Cap$11.3B
P/E Ratio
52W High$1.24
52W Low$0.37

Sino Biopharmaceutical Limited(SBMFF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · SBMFF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$31.01B$28.87B$26.20B$26.03B$26.86B
Cost of Revenue$5.56B$5.34B$4.99B$5.80B$5.33B
Gross Profit$25.45B$23.53B$21.21B$21.54B$21.53B
Gross Margin %(computed)82.07%81.51%80.95%82.76%80.15%
Operating Expenses
R&D Expenses$5.71B$5.23B$4.47B$4.33B$3.75B
G&A Expenses$0.00B$2.08B$1.87B$2.20B$2.19B
Total Operating Expenses$18.81B$17.39B$15.54B$15.95B$17.19B
Operating Income$6.64B$6.14B$5.79B$5.59B$5.08B
Operating Margin %(computed)21.40%21.26%22.08%21.46%18.91%
Interest Income$0.62B$0.50B$0.19B$0.20B$0.16B
Interest Expense$0.27B$0.30B$0.50B$0.43B$0.31B
Income Before Tax$6.76B$5.28B$5.41B$5.21B$18.57B
Income Tax Expense$1.59B$0.49B$0.80B$0.70B$1.96B
Net Income$2.28B$3.50B$2.33B$2.54B$14.61B
Net Margin %(computed)7.36%12.12%8.90%9.77%54.38%
Per Share & EBITDA
EPS (Basic)$0.13$0.20$0.08$0.11$0.78
Wtd Avg Shares18.00B17.24B23.39B18.62B18.77B
EBITDA$7.79B$6.11B$6.98B$6.69B$19.87B
EBITDA Margin %(computed)25.12%21.16%26.64%25.71%73.99%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CNY · B

深入了解Sino Biopharmaceutical Limited

关于Sino Biopharmaceutical Limited(SBMFF)损益表

Sino Biopharmaceutical Limited(SBMFF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,SBMFF实现营收$31.01B,毛利润$25.45B(毛利率82.07%),净利润$2.28B(净利率7.36%)。

常见问题

SBMFF · 4 问

Sino Biopharmaceutical Limited(SBMFF)2025财年营收为$31.01B,同比up7.4%。

SBMFF revenueSBMFF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09